333

HUAREN PHARMACEUTI

No trades
See on Supercharts
Market capitalization
‪3.91 B‬CNY
‪180.82 M‬CNY
‪1.59 B‬CNY
‪1.18 B‬
Beta (1Y)
1.26

About HUAREN PHARMACEUTI

CEO
Liang Hong
Headquarters
Qingdao
Employees (FY)
‪2.26 K‬
Founded
1998
ISIN
CNE100000SW1
FIGI
BBG000DZ8HS1
Huaren Pharmaceutical Co., Ltd. engages in development, manufacture, and sale of non polyvinyl chloride and non-PVC large capacity preparations. Its products include basic, therapeutic, cosmetics, sanitary, disposable medical products and nutritional infusion categories. The company was founded on May 20, 1998 and is headquartered in Qingdao, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 300110 is 3.37 CNY — it has increased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUAREN PHARMACEUTI stocks are traded under the ticker 300110.
HUAREN PHARMACEUTI is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
300110 stock is 2.10% volatile and has beta coefficient of 1.26. Check out the list of the most volatile stocks — is HUAREN PHARMACEUTI there?
Yes, you can track HUAREN PHARMACEUTI financials in yearly and quarterly reports right on TradingView.
300110 stock has fallen by 0.88% compared to the previous week, the month change is a 8.92% fall, over the last year HUAREN PHARMACEUTI has showed a 17.60% decrease.
300110 net income for the last quarter is ‪54.80 M‬ CNY, while the quarter before that showed ‪41.18 M‬ CNY of net income which accounts for 33.08% change. Track more HUAREN PHARMACEUTI financial stats to get the full picture.
Today HUAREN PHARMACEUTI has the market capitalization of ‪3.96 B‬, it has decreased by 0.28% over the last week.
Yes, 300110 dividends are paid annually. The last dividend per share was 0.02 CNY. As of today, Dividend Yield (TTM)% is 0.63%. Tracking HUAREN PHARMACEUTI dividends might help you take more informed decisions.
HUAREN PHARMACEUTI dividend yield was 0.50% in 2022, and payout ratio reached 13.73%. The year before the numbers were 0.38% and 16.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 300110 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUAREN PHARMACEUTI stock right from TradingView charts — choose your broker and connect to your account.
300110 reached its all-time high on Jan 17, 2018 with the price of 14.20 CNY, and its all-time low was 1.62 CNY and was reached on Jan 17, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has ‪2.26 K‬ employees. See our rating of the largest employees — is HUAREN PHARMACEUTI on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUAREN PHARMACEUTI technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUAREN PHARMACEUTI stock shows the sell signal. See more of HUAREN PHARMACEUTI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.